Statin Review: No Risk of Cancer, Memory Loss (CME/CE)
(MedPage Today) -- Statins do not confer an increased risk of cancer or cognitive decline, but a small risk for diabetes should be considered when prescribing the drugs to patients with a low cardiovascular risk, according to a review.
No comments:
Post a Comment